Biological аge of patients with ischemic heart disease under atorvastatin therapy
The aim of this study was to investigate the efficacy of atorvastatin (Trovan®, Pharmacare Int. Co.) in patients with ischemic heart disease with hypolipidic and pleotropical effect. Therapy with atorvastatin has been shown to provide stable lipid-lowering effect. Long-term therapy demonstrates a positive effect on the biological age of patients.